Coexistence of Vancomycin-Resistant Enterococci and Staphylococcus aureus in the Intestinal Tracts of Hospitalized Patients

Clinical Infectious Diseases

Volumn 37, Issue 7, 2003, Pages 875-881

  Ray, Amy J ^a   Pultz, Nicole J ^c   Bhalla, Anita ^b   Aron, David C ^d   Donskey, Curtis J ^c  

^a Louis Stokes Cleveland Vet Aff M ^*  (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Infectious Diseases Section   (United States)

^d Ctr for Qual Improvement Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; METICILLIN; METRONIDAZOLE; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM COLONY; BACTERIUM ISOLATE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITY; ENTEROCOCCUS FAECIUM; EVALUATION; FECES ANALYSIS; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTESTINE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FECES; FEMALE; HUMANS; INTESTINES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0142043961     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377451     Document Type: Article

References (37)

1. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342-7.
2. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. JAMA 2002; 288:2116.
3. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343:1925-32.
4. Sherertz RJ, Reagon DR, Hampton KD, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996; 124:539-47.
5. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994; 38:409-14.
6. Squier C, Rihs JD, Risa KJ, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002; 23:495-501.
7. Rimland D, Roberson BE. Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1986; 24:137-8.
8. Dupeyron C, Campillo B, Mangeney N, Bordes M, Richardet JP, Leluan G. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections. Infect Control Hosp Epidemiol 2001; 22:427-32.
9. Gravet A, Rondeau M, Harf-Monteil C, et al. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-LukD. J Clin Microbiol 1999; 37:4012-9.
10. Schiller B, Cheorazzi N, Farber BF. Methicillin-resistant staphylococcal enterocolitis. Amer J Med 1998; 105:164-6.
11. Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP. Seeking vancomycin-resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci. Clin Infect Dis 1999; 29:1566-8.
12. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A3. Wayne, PA: NCCLS, 1993.
13. Hoyen C, Rice LB, Conte S, Jacobs MR, Walsh-Sukys M, Toltzis P. Use of real time pulsed field gel electrophoresis to guide interventions during a nursery outbreak of Serratia marcescens infection. Pediatr Infect Dis J 1999; 18:357-60.
14. Tenover FC, Arbeit R, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
15. Manian FA, Senkel D, Zack J, Meyer L. Routine screening for methicillin-resistant Staphylococcus aureus among patients newly admitted to an acute rehabilitation unit. Infect Control Hosp Epidemiol 2002; 23:516-9.
16. Kato-Matsunaga N, Okonogi K. Gastrointestinal colonization by methicillin-resistant Staphylococcus aureus in immunosuppressed mice. Infect Immun 1996; 64:4231-5.
17. Ito Y, Tanaka M, Shimazaki M, et al. Detection of methicillin-resistant Staphylococcus aureus (MRSA) - relation between respiratory tract and gastro-intestinal tract. Kansenshogaku Zasshi 1997; 71:207-13.
18. Yoshida Y. Methicillin-resistant Staphylococcus aureus proliferation in the rat gut is influenced by gastric acid inhibition and the administration of antibiotics. Surg Today 1999; 29:327-37.
19. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-44.
20. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002; 23:436-40.
21. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180:384-90.
22. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. Evidence for extensive resistance gene transfer among Bacteroides spp and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 2001; 67:561-8.
23. Stinear TP, Olden DC, Johnson PDR, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human feces. Lancet 2001; 357:855-6.
24. Patel R. Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. FEMS Microbiol Lett 2000; 185:1-7.
25. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72:195-8.
26. Interim guidelines for prevention and control of staphylococcal infections associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 1997; 46:626-8, 635.
27. Ray AJ, Hoyen CK, Das SM, Taub TF, Eckstein EC, Donskey CJ. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA 2002; 287:1400-1.
28. Beezhold DW, Slaughter S, Hayden MK, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1997; 24:704-6.
29. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-10.
30. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002; 23:424-8.
31. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002; 35:18-25.
32. Silvestri L, Milanese M, Oblach L, et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 2002; 30:391-9.
33. Maraha B, van Halteren J, Verzijl JM, Wintermans RG, Buiting AG. Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin. Clin Microbiol Infect 2002; 8:671-5.
34. Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. Effect of oral Bacillus coagulans administration on density and persistence of colonization with vancomycin-resistant enterococci in the mouse gastrointestinal tract. Lett Appl Microbiol 2001; 33:84-8.
35. Wong MT, Kauffman CA, Standiford HC, et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33:1476-82.
36. Baden LR, Critchley IA, Sahm DF, et al. Molecular characterization of vancomycin-resistant enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin. J Clin Microbiol 2002; 40:1160-3.
37. Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999; 29:361-6.